XL228

DRUG2 trials

Sponsors

Exelixis

Conditions

CancerChronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveLymphoma

Phase 1

Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia

TerminatedNCT00464113

ExelixisChronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Start: 2007-05-31End: 2011-04-30Updated: 2015-08-21

Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

TerminatedNCT00526838

ExelixisCancer, Lymphoma

Start: 2007-09-30End: 2010-12-31Updated: 2015-08-21